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Science
What is it famous for?  Being in the
‘top two’ science journals by age and
prestige, along with its long-time
rival, Nature. Both remain the only
weekly science journals, publishing
in all areas, from astronomy to
zoology, and aiming to reach the
vanishing ‘Renaissance man’ — a
reader interested in research from
fields far from his/her own.
What’s distinctive about Science?  At the
moment, Science has arguably the
more lively and readable ‘front
matter’ — news and current affairs
coverage, and reviews of the science
reported in its own and other journals’
pages — and it remains perceptibly
American, both in style and content.
But as to which is the most prestigious
science journal, opinions differ now as
they have over the two journals’ 118-
year joint history. One distinction is
that Science is not, officially, a journal
sold by subscription: it is given away
free to members of the American
Association for the Advancement of
Science (many of whom join the
AAAS solely to receive Science) and it
is meant to serve as a “forum for the
presentation and discussion of
important issues related to the
advancement of science, including
minority or conflicting views.”
What difference does being the ‘official
organ’ of the AAAS make?  One big
difference is circulation; because the
range of AAAS members includes, for
example, US high school teachers,
Science has 160,000 subscribers —
several times as many as other all-of-
science journals, such as Nature
(56,000) and the Proceedings of the
National Academy of Sciences, USA
(8900). Another perceived difference
is in the range of subjects covered.
Science has the reputation for
publishing research on given topics,
whether or not each paper can be said
to be of significant interest to those
outside the field, whereas other
journals can be accused of following
(or setting) scientific fashions by
publishing only what’s ‘hot’. And
although Science is autonomous
editorially, the AAAS has the last say
on its budget.
So the Editor decides what’s in the
journal? In the broadest sense, yes,
but Science has, against the odds,
maintained the tradition of having
an active, respected scientist as its
Editor-in-Chief. The current
incumbent, Floyd E. Bloom, like his
immediate predecessor Daniel E.
Koshland Jr, maintains a laboratory
in California, as well as being Editor-
in-Chief of a weekly journal
published from Washington DC. So,
although he has a role in policy-
making and determining the general
direction of the journal, he is not the
person making decisions about the
vast majority of submitted
manuscripts. Science’s full-time
editorial staff and advisory Editorial
Board make the decisions on
individual papers (with the two
layers introducing inevitable delays
that frustrate authors).
Has anything changed in 118 years?
Apart from the changes in typography
and page layout that make all journals
look old-fashioned within a decade or
two, the main change of recent years
has been the move into internet
publishing. Science was among the
first wave of journals to put its full
text online (whereas Nature is among
the laggards); to make some features,
such as additional news stories and
career development stories, available
only online; and to make an
additional charge to print ‘subscribers’
who want to see the journal online (at
http://www.sciencemag.org/). The
other ‘big push’ has seen the opening
of a Science editorial office in the UK
and the addition of staff in France,
Germany, Japan and China,
presumably in an attempt to convince
the rest of the world that the first A in
AAAS doesn’t imply any xenophobia.
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Transcription regulation in eukaryotes
comprises two overlapping systems:
transcription factors, which are largely
responsible for specificity, and
chromatin-associated factors, which
mediate changes in chromatin
conformation, for example,
nucleosome unfolding [1,2]. The
evolutionary history of these proteins
is generally unclear. Some are highly
conserved among eukaryotes and
appear to have evolved early in
eukaryotic evolution, whereas others
seem to be confined to distinct
eukaryotic lineages; most have no
obvious orthologs in bacteria or
archaea. We show here that three
unrelated families of transcriptional
regulators, Gal80, TAFII150, and
Cdc68/Spt16, derive from ancient
enzymatic domains and that their
evolution included disruption of
enzymatic active sites.
Gal80 is a negative regulator of
Gal4, which is the transcriptional
activator of galactose-regulated genes
[3,4]. Gal80 is conserved in two yeast
species, Saccharomyces cerevisiae and
Kluyveromyces lactis, but no orthologs
are currently detectable in other
species. Sequence comparisons
indicate that Gal80 is related to a
widespread family of oxidoreductases
typified by glucose-fructose
oxidoreductase (GFOR; Figure 1a).
The sequence similarity between
Gal80 and GFOR family
oxidoreductases is statistically
significant, and the dinucleotide-
binding Rossmann fold typical of the
GFOR structure [5] appears to be
conserved in Gal80 (Figure 1a). The
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Figure 1
Ancient enzymatic domains in eukaryotic
transcription regulators. The non-redundant
protein sequence database at the NCBI was
searched using the gapped BLAST and PSI-
BLAST programs, which combine BLAST with
profile analysis [15], and the regions of low
complexity were masked using the SEG
program [16]. The gene identification
numbers (GIs) are shown to the right of each
of the sequences. The consensus sequence
is shown at the top: U, hydrophobic residues
(blue); O, small residues (red); J, charged
residues (magenta). Sequences are shown in
the single-letter amino acid code and
numbers in brackets indicate the numbers of
amino acids not included in the alignment.
(a) Alignment of Gal80 with GFOR family
oxidoreductases: PHT4, putative
oxidoreductase involved in phthalate
metabolism; DIEDH, oxidoreductase involved
in chlorobenzoate catabolism; YJHC, putative
oxidoreductase; ORF-5, putative
oxidoreductase encoded in the nanB operon;
BplA, putative oxidoreductase involved in
lipopolysaccharide biosynthesis; GFOR,
glucose-fructose oxidoreductase; YMO1,
oxidoreductase involved in rhizopine
catabolism. The probability of Gal80
matching PHT4 by chance was <10–7 as
computed by the gapped BLAST program. The
alignment was constructed using the
CLUSTALW program [17]. The consensus
includes amino acid residues conserved in all
aligned sequences. Note the glutamic
acid–lysine–proline (EKP) signature in the
active site (+++), which is conserved in the
GFOR family but disrupted in Gal80 (reverse
type and lower case), a conserved glycine-
rich loop (+++), and the residues typical of
the Rossmann fold (! ! !). The secondary
structure elements (β strand and α helix)
derived from the crystal structure of GFOR
(PDB entry 1ofg) are shown. (b) Alignment
of TAFII150 and Tsm1 with AMPN family
hydrolases: AMPN, aminopeptidase N;
APE2, aminopeptidase II; LKHA, leukotriene
A4 hydrolase; IRAP, insulin response
aminopeptidase. The probability of TAFII150
matching Synechocystis sp. AMPN by
chance was <10–19 as computed by gapped
BLAST. The alignment was constructed using
the MACAW program [18]. The consensus
includes residues conserved in all
sequences. Note that the metal-chelating
histidines (reverse type) are missing in the
transcriptional regulators. Organism
abbreviations: Sc, Saccharomyces cerevisae;
Pp, Pseudomonas putida; Af, Alcaligenes
sp.; Ec, Escherichia coli; Sp, Streptococcus
pneumoniae; Bp, Bordetella pertussis; Zm,
Zymomonas mobilis; Rm, Rhizobium meliloti;
Dm, Drosophila melanogaster; Hs, Homo
sapiens; Lh, Lactobacillus helveticus; Cp,
Cavia porcellus; Sl, Streptomyces lividans;
Ssp, Synechocystis sp.; Rn, Rattus
norvegicus. Current Biology
  

(a)
(b)
β-strand
α helix
GIs
GIs
C
catalytic site, however, which in the
GFOR superfamily contains the
conserved glutamic
acid–lysine–proline triad, is disrupted
in Gal80 (Figure 1a), suggesting that
Gal80 lacks enzymatic activity, though
it still may bind a nucleotide and/or a
sugar. These affinities of the Gal80
GFOR-related fold may account for
the ATP-dependent effect of
galactose on Gal4 inhibition [6]. 
Drosophila TAFII150 is a basal
transcription factor conserved in yeast
(Tsm1) and other eukaryotes; it is a
component of TFIID, which contacts
DNA in the vicinity of the
transcription start site [7] and
modulates promoter selectivity and
transcription activation [8]. Database
searches revealed significant sequence
similarity between TAFII150/Tsm1
and the aminopeptidase N (AMPN)
family, which includes enzymes
involved in the degradation of a
variety of peptides and leukotrienes
[9]. TAFII150 proteins contain the
four conserved blocks typical of this
family, but lack the two metal-
chelating histidines (Figure 1b). The
other conserved residues are retained,
suggesting that the transcription
regulators have the same overall
structure as the AMPN family
enzymes.
Cdc68/Spt16 is a chromatin-
associated protein that upregulates
transcription and acts antagonistically
to the RING finger protein silencer
protein San1 [10]. Likely orthologs of
Cdc68 are detectable among human
and plant expressed sequence tags
(ESTs). Sequence comparisons show
that Cdc68/Spt16 and its homologs
belong to the aminopeptidase P
(AMPP) superfamily involved in
cleaving proline-containing peptides,
creatine hydrolysis, and agropine
synthesis [11]. As in the case of
TAFII150/Tsm1, the aminopeptidase
catalytic site, centered around the
metal-chelating histidines, is
disrupted in Cdc68/Spt16, which is
therefore unlikely to possess
hydrolase activity (data not shown).
Another member of the AMPP
superfamily, Cdb1/Pas1, which is
highly conserved in eukaryotes, is a
nuclear, curved-DNA-binding protein
[12,13]. Similarly to Cdc68/Spt16,
Cdb1/Pas1 lacks two of the three
catalytic histidines (data not shown),
suggesting a more general
involvement of inactive AMPP
proteins in chromatin-associated roles. 
We have shown that three
unrelated yeast transcriptional
regulators, two of them highly
conserved among eukaryotes, have
probably evolved from ancient
enzymatic domains. In each case, the
active site is disrupted, indicating
elimination of the enzymatic activity,
with retention of the overall structure
and probably protein–protein
interactions and ligand-binding
capacities. The independent
recruitment of two aminopeptidases
for transcription regulation is of special
interest, suggesting that the innate
protein-binding properties of proteases
make them particularly prone to
recruitment for non-enzymatic roles.
The only other case of an enzyme
recruited as a eukaryotic transcription
regulator known to us — preadipocyte
factor AEBP1 — also involves a
protease, in this case an active
carboxypeptidase [14]. Systematic
analysis of the sequences and
structures of eukaryotic transcription
regulators with increasingly sensitive
computer methods will show how
common it is for them to have evolved
from enzymes.
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